[Prognostic factors in multiple myeloma]

Haematologica. 1989 Oct;74(5 Suppl):347-57.
[Article in Italian]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Cell Division
  • Drug Resistance
  • Humans
  • Immunologic Deficiency Syndromes / etiology
  • Kidney Failure, Chronic / etiology
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / pathology*
  • Myeloma Proteins / analysis
  • Neoplasm Proteins / blood
  • Neoplastic Stem Cells / pathology
  • Oncogenes
  • Prognosis
  • Thymidine Kinase / blood
  • beta 2-Microglobulin / analysis

Substances

  • Antineoplastic Agents
  • Myeloma Proteins
  • Neoplasm Proteins
  • beta 2-Microglobulin
  • Thymidine Kinase